Cheng S, Deng M, Qi L, Chen J, Cui S, Wang Y, et al. Cardiotoxicity in low-to-moderate cardiovascular risk patients undergoing anti-HER2 therapy: A prospective CMR study. Radiol Oncol [Internet]. 2025 Dec. 16 [cited 2026 Apr. 17];59(4):510-21. Available from: https://www.radioloncol.com/index.php/ro/article/view/4626